ACHC Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress SLDE Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline RERE Q1 2026 Earnings EPS Crushes Estimates by Over 700 on Operational Strength GOODO Q1 2026 Earnings Strong EPS Surprise of 5686 Boosts Investor Confidence